Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

DeepMoDRP: A Multi-Omics-Based Deep Learning Framework for Drug Response Prediction in Brain Cancer.

Yuxuan Li¹, Xiumin Shi¹, Lu Wang²

¹School of Information and Electronics, Beijing Institute of Technology, Beijing, China.

Molecular Informatics

|February 15, 2026

Summary

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prot-ΔΔG: Prediction of protein-protein binding affinity changes upon mutations with pre-training strategies.

Journal of computer-aided molecular design·2026

Same author

Deep3D-DTA: A Tri-Modal Deep Learning Framework for Binding Affinity Prediction Leveraging 3D Structural Representations of Drugs and Targets.

Interdisciplinary sciences, computational life sciences·2026

Same author

MuloAD: A Multiomics Integration Model Utilizing Graph Convolutional Networks for Alzheimer's Disease Diagnosis and Biomarker Identification.

The European journal of neuroscience·2026

Same author

Complex temporal network analysis based on the difference visibility graph for epilepsy with and without electrical status epilepticus during sleep (ESES) patients.

Health information science and systems·2026

Same author

Mid-Term Outcomes Following Endovascular Aneurysm Repair Using the INCRAFT Stent-Graft System.

Surgical innovation·2026

Same author

NK cell-associated LncRNA signature predicts prognosis and immune landscape in hepatocellular carcinoma.

Clinical and experimental medicine·2026

A new model, DeepMoDRP, accurately predicts brain tumor drug responses by integrating multi-omics data. This advancement offers hope for personalized neuro-oncology treatments and improved patient outcomes.

Area of Science:

Neuro-oncology
Computational Biology
Genomics

Background:

Existing brain tumor pharmacotherapies show limited efficacy.
Accurate predictive models are crucial for advancing neuro-oncology treatment strategies.

Purpose of the Study:

To introduce DeepMoDRP, a novel drug response prediction model for brain cancer.
To integrate diverse biological data for enhanced prediction accuracy.

Main Methods:

DeepMoDRP integrates genomic, transcriptomic, and epigenomic data.
Utilizes sparse autoencoders (AEs) and denoising AEs for dimensionality reduction.
Employs convolutional neural networks and graph neural networks for data processing and prediction.

Main Results:

Keywords:

brain cancer denoising autoencoder drug response prediction graph neural network muti‐omics

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

DeepMoDRP outperforms state-of-the-art pan-cancer models in predicting brain tumor drug responses.
Experimental results validate the model's predictive capabilities on curated brain tumor datasets.

Conclusions:

DeepMoDRP demonstrates significant promise for personalized brain tumor treatment.
The model can aid in developing more effective neuro-oncology strategies.